India's biotechnology sector has demonstrated exponential growth, reaching a valuation of $165.7 billion by 2024 and surpassing the $150 billion milestone two years ahead of the 2025 target. This trajectory is governed by the 'National Biotech Development Strategy 2021-2025', which focuses on making India a global biomanufacturing hub. The Department of Biotechnology (DBT) and its public sector enterprise, the Biotechnology Industry Research Assistance Council (BIRAC), have operationalized this vision by creating a decentralized innovation landscape. Currently, 94 bio-incubators are functional across 25 States and Union Territories, providing the necessary infrastructure for early-stage startups to bridge the gap between laboratory research and commercial application. The strategy emphasizes three pillars: fostering innovation, scaling domestic manufacturing, and enhancing institutional capacity to support a robust bio-entrepreneurship culture.
Loading page, please wait…